Larimar Therapeutics, Inc. (LRMR)
NASDAQ·Healthcare·Biotechnology
$3.83
+0.13%
Mkt Cap $393.72M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$8.00
Range $5.00 – $11.00
Implied Upside
+109.2%
Consensus $8.00 vs current $3.83
NASDAQ·Healthcare·Biotechnology
$3.83
+0.13%
Mkt Cap $393.72M
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$8.00
Range $5.00 – $11.00
+109.2%
Consensus $8.00 vs current $3.83